Although the BDNF-MAPK-CREB pathway plays a key role in the pathophysiology and treatment of depression, the molecular mechanisms through which GC induces adaptive changes in this signaling cascade are not fully understood. The gene discussed is CREB1; the disease is depressive symptom measurement.